Renal Cell Carcinoma: Epidemiology and Classification

Renal cell carcinoma (RCC) is the most common malignant tumour of the kidney in adults, arising from the epithelium of the renal tubules. It is not a single disease but a family of histological and molecular subtypes—clear cell, papillary, and chromophobe being the most frequent—each with distinct genetics and behaviour. Many cases are now detected incidentally on imaging performed for other reasons.

Definition

Renal cell carcinoma is a malignant epithelial neoplasm originating from the renal tubular epithelium, classified by the WHO into histological subtypes (predominantly clear cell, papillary, and chromophobe) and staged using the TNM system.

Scope

This entry covers the descriptive epidemiology and histopathological classification of renal cell carcinoma: its incidence and risk factors, the major WHO tumour subtypes, the role of tumour grade and TNM stage, and the hereditary syndromes associated with kidney cancer. It is a reference-educational overview and does not provide diagnostic or treatment recommendations.

Core questions

• What are the main histological subtypes of renal cell carcinoma and how do they differ?
• What are the established risk factors for kidney cancer?
• How are RCC tumours graded and staged?
• Which hereditary syndromes predispose to renal cell carcinoma?

Key concepts

• Clear cell renal cell carcinoma
• Papillary and chromophobe subtypes
• VHL gene inactivation
• WHO/ISUP nuclear grade
• TNM staging
• Incidental detection
• Hereditary renal cancer syndromes (e.g., von Hippel-Lindau)

Mechanisms

Clear cell RCC, the most common subtype, is characteristically associated with inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene, leading to stabilisation of hypoxia-inducible factors and downstream activation of angiogenic and proliferative pathways (Hsieh, 2017; Cohen, 2005). Papillary and chromophobe subtypes have different genetic drivers and arise from distinct portions of the nephron. Tumours are categorised histologically under the WHO classification and assigned a nuclear grade, while the TNM system describes anatomical extent (Moch, 2016).

Clinical relevance

The classic triad of flank pain, haematuria, and a palpable mass is now uncommon, as most renal cell carcinomas are found incidentally during abdominal imaging (Cohen, 2005; Rini, 2009). Histological subtype, tumour grade, and stage are the principal descriptors that pathologists and clinicians use to characterise a tumour. This entry describes how the disease is classified and is not a basis for individual diagnostic or treatment decisions.

Epidemiology

Kidney cancer, of which renal cell carcinoma is the dominant form, is among the more common malignancies worldwide, with incidence higher in men than women and rising in part because of increased incidental detection (Bray, 2024). Established risk factors include cigarette smoking, obesity, hypertension, and acquired cystic kidney disease in patients on long-term dialysis (Hsieh, 2017; Rini, 2009).

Evidence & guidelines

Histological classification follows the WHO classification of tumours of the urinary system and male genital organs (Moch, 2016), and grading commonly uses the WHO/ISUP nuclear grading system. Anatomical extent is described by the TNM staging system. Disease-specific management guidelines are published by professional bodies such as the European Association of Urology and the American Urological Association; readers should consult the current versions.

Seminal works

• hsieh-2017
• cohen-2005
• moch-2016
• rini-2009

Frequently asked questions

What is the most common type of kidney cancer?

Renal cell carcinoma is the most common malignant kidney tumour in adults, and clear cell carcinoma is its most frequent histological subtype.

Why are many renal cell carcinomas found by accident?

Widespread use of abdominal ultrasound and CT for unrelated symptoms means that many small, asymptomatic renal tumours are now detected incidentally rather than through the classic symptom triad.